25 July 2018

The Departments of Laboratory Medicine and Hematology entered into a partnership with the Social impact foundation MWH4impact on Natural Killer cell therapy.


In a 4-year program MWH4impact financially supports specialized staff to enable the “market-readiness” of the promising Natural Killer (NK) cell therapy product developed in the Radboudumc. This involves the upscaling and implementation strategy of an off-the-shelf NK cell product generated from umbilical cord blood stem cells.

Harry Dolstra, (photo above), Joop Jansen and their team, theme Cancer development and immune defense, have succeeded in growing these NK cells from stem cells in large numbers. They received grants from KWF to examine in patients whether these NK cells can effectively combat leukemia and ovarian cancer cells. Together with MWH4impact they are in an unique position to further develop and bring the NK cell therapy to patients with cancer.


 

Related news items


European Commission Initiative on Breast Cancer (ECIBC) Guidelines

13 August 2019

In Annals of internal medicine Mireille Broeders and colleagues from the ECIBC Guidelines Development Group described the methods used to develop person-centered evidence-based recommendations for screening and diagnosis of breast cancer.

read more

Circulation publication for exercise physiologists

13 August 2019

Thijs Eijsvogels and Vincent Aengevaeren showed that exercise-incuded elevations of troponin concentrations are predictive of major adverse cardiovascular events and mortality.

read more

DELA, Radboudumc and Games for Health start a new project to fight loneliness among elderly using games

12 August 2019

More than half of people aged 75 and over feel their selves lonely every now and then. A special collaboration between DELA, Radboudumc, and Games for Health will investigate whether joined gaming between elderly and young people can alleviate this social problem.

read more

Floris Schreuder received Dekker grant

6 August 2019

Floris Schreuder received one of the ten Dekker grants from the Dutch Heart Foundation (Hartstichting).

read more

A warm welcome for a new RIMLS colleague Nico Sommerdijk

5 August 2019

As of 1 August we welcome Nico Sommerdijk as our new colleague at the RIMLS. Nico will join the department of Biochemistry, with his research group “Biochemistry of Mineralized Tissues”.

read more

Bart Kiemeney finishes 1st in the Tour and raises thousands of euros

30 July 2019

With over €43,000 on the counter, Kiemeney can see the Tour de France as a great success.

read more